Development of thalidomide-loaded biodegradable devices and evaluation of the effect on inhibition of inflammation and angiogenesis after subcutaneous application - 08/05/15
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 8 |
| Iconographies | 7 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Purpose |
To develop thalidomide-loaded poly-lactide-co-glycolide implants and evaluate its in vivo release and biological activity against inflammation and angiogenesis after subcutaneous administration.
Methods |
Implants were prepared by the hot molding technique and characterized using stereomicroscopy, thermal analysis and X-ray diffraction. Swiss mice, divided in groups 1–3, received a subcutaneous implant containing 25% (w/w), 50% (w/w) or 75% (w/w) of thalidomide, respectively (n=6). The drug levels were determined during a 28-day study period. The toxicity associated with the implants was evaluated by light microscopy. The potential of the developed implant in the inhibition of inflammation and angiogenesis was evaluated in vivo using the sponge model.
Results |
Thalidomide implant was developed and its characterization proved the stability of the drug and the polymer during preparation. Release profiles in vivo demonstrated an extended release of thalidomide from the implants during the 28 days. Histological evaluation did not show any sign of intense local inflammatory response to the presence of the implants in the subcutaneous pouch. The thalidomide implant reduced the number of vessels and N-acetyl-b-glucosaminidase (NAG) in vivo.
Conclusion |
The biodegradable implants delivered safe doses of thalidomide that were also effective to induce angiogenesis and inflammation regression.
Le texte complet de cet article est disponible en PDF.Keywords : PLGA, Delivery system, Sponge model, Anti-angiogenic, Anti-inflammatory
Plan
Vol 71
P. 21-28 - avril 2015 Retour au numéro
Article précédent
- Cerebral ischemia-induced mitochondrial changes in a global ischemic rat model by AFM
- Eunkuk Park, Seok Keun Choi, Sung Wook Kang, Youngmi Kim Pak, Gi-Ja Lee, Joo-Ho Chung, Hun-Kuk Park
- Oxidative modification induced by photodynamic therapy with Photofrin®II and 2-methoxyestradiol in human ovarian clear carcinoma (OvBH-1) and human breast adenocarcinoma (MCF-7) cells
- Jolanta Saczko, Anna Choroma?ska, Nina Rembia?kowska, Magda Dubi?ska-Magiera, Iwona Bednarz-Misa, Julia Bar, Anna Marcinkowska, Julita Kulbacka
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?